Amgen Pivots to Genome Valley, Expands Global Research Network

Amgen, a leading US-based biotechnology company, has announced plans to establish a new science and innovation center at Genome Valley in Hyderabad. This expansion is set to become operational by 2027 and will join Amgen's global R&D network of seven research laboratories.

The new center will focus on bringing together scientists and technologists from various disciplines, including discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine. By integrating experimental science with data and technology, Amgen aims to accelerate its research capabilities and develop innovative medicines for patients.

Amgen's existing Genome Valley site in Hyderabad will complement the new center, enabling closer integration of laboratory-based science with technology. This strategic move reflects Hyderabad's growing reputation as a global hub for high-value research.